Cytomegaloviral pneumonitis is a severe lung infection caused by the cytomegalovirus (CMV), primarily affecting immunocompromised individuals, such as those with HIV/AIDS or organ transplant recipients. This condition can lead to significant morbidity and mortality, necessitating accurate diagnosis and documentation. The ICD-10 Code B25.0 facilitates precise coding for clinical encounters, ensuring appropriate billing and public health reporting.
What is ICD-10 Code B25.0 for Cytomegaloviral pneumonitis?
ICD-10 Code B25.0 represents Cytomegaloviral pneumonitis, an infectious lung disease caused by the cytomegalovirus. This code is used when documenting cases of pneumonitis related to CMV infection, particularly in patients with weakened immune systems. Accurate use of this code is essential for clinical documentation, billing, and tracking epidemiological data.
ICD-10 Code B25.0 – Clinical Definition and Explanation of Cytomegaloviral pneumonitis
Cytomegaloviral pneumonitis is primarily caused by the reactivation of cytomegalovirus in immunocompromised patients. The condition can progress rapidly, leading to respiratory failure and requiring immediate medical intervention. Early recognition and treatment are critical to improving patient outcomes.
Key Clinical Features:
- Common in immunocompromised patients, especially those with HIV/AIDS or post-transplant.
- Symptoms include cough, fever, dyspnea, and hypoxemia.
- Chest imaging may reveal bilateral infiltrates or ground-glass opacities.
- Diagnosis often confirmed through PCR testing for CMV in respiratory secretions.
ICD-10 Code B25.0 for Cytomegaloviral pneumonitis – SOAP Notes & Clinical Use
In SOAP notes, ICD-10 Code B25.0 is utilized to document the diagnosis of Cytomegaloviral pneumonitis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
What Does ICD-10 Code B25.0 for Cytomegaloviral pneumonitis Mean in SOAP Notes?
ICD-10 Code B25.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cytomegaloviral pneumonitis. This linkage is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code B25.0 – Cytomegaloviral pneumonitis
Cytomegaloviral pneumonitis often necessitates hospitalization due to the risk of respiratory failure. Antiviral therapy is the cornerstone of treatment.
Antibiotic Therapy:
- Ganciclovir: First-line treatment, typically administered intravenously for 2-3 weeks.
- Foscarnet: Alternative for ganciclovir-resistant cases, duration based on clinical response.
- Valganciclovir: Oral option for maintenance therapy after initial treatment.
Supportive Care:
- Oxygen therapy to manage hypoxemia.
- Fluid management to prevent dehydration.
- Monitoring for complications such as secondary infections.
Infection Control:
- Implement standard precautions to prevent CMV transmission.
- Isolate immunocompromised patients during outbreaks.
- Educate healthcare staff on CMV infection control measures.
How to Document Symptoms of Cytomegaloviral pneumonitis (ICD-10 B25.0) in SOAP Notes
Subjective:
- Patient reports persistent cough and shortness of breath.
- History of recent fever and chills.
- Known immunocompromised status due to HIV/AIDS.
- Increased fatigue and difficulty performing daily activities.
Objective:
- Vital signs: Elevated respiratory rate and low oxygen saturation.
- Auscultation reveals bilateral crackles.
- Chest X-ray shows bilateral infiltrates.
- Laboratory tests confirm positive CMV PCR in respiratory secretions.


Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreSOAP Note Guidelines for Diagnosing Cytomegaloviral pneumonitis (ICD-10 Code B25.0)
Assessment:
- Diagnosis: Cytomegaloviral pneumonitis, moderate severity.
- ICD-10 Code: B25.0.
- Contributing factors: Immunocompromised state due to HIV.
- Consider differential diagnoses such as bacterial pneumonia.
Plan:
- Initiate ganciclovir therapy and monitor for side effects.
- Provide supplemental oxygen as needed.
- Educate patient on signs of worsening respiratory distress.
- Schedule follow-up in one week to reassess clinical status.
Treatment & Plan Section for ICD-10 Code B25.0 – Cytomegaloviral pneumonitis
- First-line pharmacologic treatment includes ganciclovir.
- Non-pharmacologic strategies involve patient education on infection prevention.
- Monitoring includes regular assessment of respiratory function and CMV viral load.
- Follow-up practices should include scheduled visits to evaluate treatment response.
Using ICD-10 Code B25.0 for Cytomegaloviral pneumonitis in Billing & SOAP Note Compliance
- Select appropriate ICD-10 code based on clinical documentation of CMV pneumonitis.
- Ensure Subjective (S) and Objective (O) sections clearly reflect symptoms and findings.
- Align treatment plans with clinical guidelines to support justified billing.
- Include relevant CPT codes that correspond to the services provided.
Related ICD-10 Codes Often Used with Cytomegaloviral pneumonitis
ICD-10 Code B25.0 in Medical Billing and Insurance for Cytomegaloviral pneumonitis
ICD-10 Code B25.0 is crucial for billing in hospital, emergency room, or infectious disease settings, ensuring accurate reimbursement for services rendered.
Billing Notes:
- Document all relevant clinical findings to support the use of B25.0.
- Use this code in conjunction with other relevant codes for comprehensive billing.
- Ensure that the diagnosis is clearly linked to the patient's clinical presentation.
- Review payer-specific guidelines for any additional documentation requirements.
Common CPT Pairings:
CPT Code | Description |
---|
99223 | Initial hospital care, typically 70 minutes or more. |
87556 | Qualitative detection of CMV DNA in respiratory specimens. |
94640 | Pressurized inhalation treatment for respiratory conditions. |